| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2005-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd5da4f6d1a08a230f22015ba06a28f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc06f433df5a90d5fe39cee29588bb9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb1751d6ba15979ed8624eeb22ad64b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00825179e3f2e761c9b135ab3cee1a39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99050ca19d477229e2e2859ff2cc2219
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21bac24f581c2962fa426f7e82ad6a94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a88bf16d9c0efa4ac14798f1f97ded35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e87c66dbb5ec84275a48ce70dd0f7f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fd8910af6931055a78e2cf21c50864c |
| publicationDate |
2009-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7544677-B2 |
| titleOfInvention |
Inhibitors of Akt activity |
| abstract |
The present invention is directed to compounds which contain substituted 5-deazapteridine moieties which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9387216-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884067-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8822524-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008287457-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7910561-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10098896-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010009397-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808472-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9439912-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8614221-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012004240-A1 |
| priorityDate |
2004-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |